95 related articles for article (PubMed ID: 25880144)
1. Modulatory actions of o-coumaric acid on carcinogen-activating cytochrome P450 isozymes and the potential for drug interactions in human hepatocarcinoma cells.
Sen A; Terzioglu G; Atmaca P; Celik G; Ozgun O; Arslan S
Pharm Biol; 2015; 53(9):1391-8. PubMed ID: 25880144
[TBL] [Abstract][Full Text] [Related]
2. Drug interaction potential of Ankaferd blood stopper® in human hepatocarcinoma cells.
Semiz A
Turk J Med Sci; 2023 Apr; 53(2):455-462. PubMed ID: 37476879
[TBL] [Abstract][Full Text] [Related]
3. Anticarcinogenic effect and carcinogenic potential of the dietary phenolic acid: o-coumaric acid.
Sen A; Atmaca P; Terzioglu G; Arslan S
Nat Prod Commun; 2013 Sep; 8(9):1269-74. PubMed ID: 24273864
[TBL] [Abstract][Full Text] [Related]
4. Genistein Affects Expression of Cytochrome P450 (CYP450) Genes in Hepatocellular Carcinoma (HEPG2/C3A) Cell Line.
Lepri SR; Sartori D; Semprebon SC; Baranoski A; Coatti GC; Mantovani MS
Drug Metab Lett; 2018; 12(2):138-144. PubMed ID: 29984664
[TBL] [Abstract][Full Text] [Related]
5. Diverse action of acrylamide on cytochrome P450 and glutathione S-transferase isozyme activities, mRNA levels and protein levels in human hepatocarcinoma cells.
Sen A; Ozgun O; Arinç E; Arslan S
Cell Biol Toxicol; 2012 Jun; 28(3):175-86. PubMed ID: 22392284
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of cyclophosphamide and Rhizoma Paridis Saponins on anti-hepatocarcinoma mice and effects on cytochrome p450 enzyme expression.
Man S; Li Y; Fan W; Gao W; Liu Z; Zhang Y; Liu C
Steroids; 2014 Feb; 80():1-6. PubMed ID: 24291418
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of spirulina platensis on carcinogen-activating cytochrome P450 isozymes and potential for drug interactions.
Savranoglu S; Tumer TB
Int J Toxicol; 2013; 32(5):376-84. PubMed ID: 24082030
[TBL] [Abstract][Full Text] [Related]
8. Salvianolic acid B modulates the expression of drug-metabolizing enzymes in HepG2 cells.
Wang QL; Wu Q; Tao YY; Liu CH; El-Nezami H
Hepatobiliary Pancreat Dis Int; 2011 Oct; 10(5):502-8. PubMed ID: 21947724
[TBL] [Abstract][Full Text] [Related]
9. HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved.
Tolosa L; Gómez-Lechón MJ; Pérez-Cataldo G; Castell JV; Donato MT
Arch Toxicol; 2013 Jun; 87(6):1115-27. PubMed ID: 23397584
[TBL] [Abstract][Full Text] [Related]
10. Sulindac regulates the aryl hydrocarbon receptor-mediated expression of Phase 1 metabolic enzymes in vivo and in vitro.
Ciolino HP; MacDonald CJ; Memon OS; Bass SE; Yeh GC
Carcinogenesis; 2006 Aug; 27(8):1586-92. PubMed ID: 16531450
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cytochrome P450 2J2 by tanshinone IIA induces apoptotic cell death in hepatocellular carcinoma HepG2 cells.
Jeon YJ; Kim JS; Hwang GH; Wu Z; Han HJ; Park SH; Chang W; Kim LK; Lee YM; Liu KH; Lee MY
Eur J Pharmacol; 2015 Oct; 764():480-488. PubMed ID: 26209360
[TBL] [Abstract][Full Text] [Related]
12. Effects of aescin on cytochrome P450 enzymes in rats.
Huang Y; Zheng SL; Zhu HY; Xu ZS; Xu RA
J Ethnopharmacol; 2014; 151(1):583-90. PubMed ID: 24252494
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 expression and activities in human tongue cells and their modulation by green tea extract.
Yang SP; Raner GM
Toxicol Appl Pharmacol; 2005 Jan; 202(2):140-50. PubMed ID: 15629189
[TBL] [Abstract][Full Text] [Related]
14. Cis-Nerolidol Induces Endoplasmic Reticulum Stress and Cell Death in Human Hepatocellular Carcinoma Cells through Extensive CYP2C19 and CYP1A2 Oxidation.
Biazi BI; Zanetti TA; Baranoski A; Corveloni AC; Mantovani MS
Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):334-341. PubMed ID: 28256105
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of natural prenyloxycinnamic acids on human cytochrome P450 isozyme activity and expression.
Genovese S; Epifano F; Curini M; Menger D; Zembruski NC; Weiss J
Phytomedicine; 2011 May; 18(7):586-91. PubMed ID: 21112752
[TBL] [Abstract][Full Text] [Related]
16. Altered Gene Expression of Cytochrome P450 and ABC Transporter in Human Hepatocellular Carcinoma HepG2 Cells Exposed to Bardoxolone Methyl.
Nagai K; Fukuno S; Miura T; Yasuda-Imanishi E; Konishi H
Drug Res (Stuttg); 2023 Oct; 73(8):473-475. PubMed ID: 37591260
[TBL] [Abstract][Full Text] [Related]
17. Identification and hepatic expression profiles of cytochrome P450 1-4 isozymes in common minke whales (Balaenoptera acutorostrata).
Niimi S; Kim EY; Iwata H; Watanabe MX; Yasunaga G; Fujise Y; Tanabe S
Comp Biochem Physiol B Biochem Mol Biol; 2007 Aug; 147(4):667-81. PubMed ID: 17526421
[TBL] [Abstract][Full Text] [Related]
18. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
Buetler TM; Bammler TK; Hayes JD; Eaton DL
Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
[TBL] [Abstract][Full Text] [Related]
19. Role of dihydromyricetin in cytochrome P450-mediated metabolism and carcinogen activation.
Bostikova Z; Moserova M; Pavek P; Stiborova M; Hodek P
Neuro Endocrinol Lett; 2015; 36 Suppl 1():46-52. PubMed ID: 26757127
[TBL] [Abstract][Full Text] [Related]
20. Heterologous expression of human cytochrome P450 2E1 in HepG2 cell line.
Zhuge J; Luo Y; Yu YN
World J Gastroenterol; 2003 Dec; 9(12):2732-6. PubMed ID: 14669323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
